Skip to main content

Table 2 Treatment delivery

From: Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy

Characteristic Arm without CTV n (%) Arm with CTV n (%)
No. of eligible patients 54(100) 35(100)
Treatment schedule   
  Induction chemo + RT 6(11.1) 8(22.9)
  Concurrent chemo alone 2(3.7) 2(5.7)
  Induction + concurrent t adjuvant chemo 11(20.4) 13(37.1)
  Induction + concurrent chemo 26(48.1) 10(28.6)
  Concurrent + adjuvant chemo 8(14.8) 2(5.7)
  Induction + RT adjuvant chemo 1(1.9) 0(0)
Induction chemo (cycles)   
  0 10(18.5) 4(11.4)
  1 15(27.8) 9(25.7)
  2 13(24.1) 7(20.0)
  ≥3 16(29.6) 15(42.9)
Concurrent chemo (cycles)   
  0 7(13.0) 8(22.8)
  1 9(16.7) 5(14.3)
  2 34(63.0) 14(40.0)
  3 4(7.4) 8(22.8)
Adjuvant chemo (cycles)   
  0 34(63.0) 20(57.1)
  1 8(14.8) 5(14.3)
  2 11(20.4) 9(25.7)
  3 1(1.9) 1(2.9)
PCI   
  Without PCI 25(46.3) 18(51.4)
  With PCI 29(53.7) 17(48.6)